{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T19:03:17Z","timestamp":1770490997048,"version":"3.49.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-020-01257-6","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T19:03:04Z","timestamp":1615834984000},"page":"41-58","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5511-9912","authenticated-orcid":false,"given":"A.","family":"Auerbach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. J.","family":"Schmieg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. S.","family":"Aguilera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"1257_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1542\/pir.2017-0249","volume":"39","author":"MS Weinstock","year":"2018","unstructured":"Weinstock MS, Patel NA, Smith LP. Pediatric cervical lymphadenopathy. Pediatr Rev. 2018;39:433\u201343.","journal-title":"Pediatr Rev"},{"key":"1257_CR2","first-page":"505","volume-title":"Pediatric Head and Neck Pathology","author":"J Schowinsky","year":"2017","unstructured":"Schowinsky J. Reactive and malignant diseases of hematopoietic and lymphoid tissues. In: Greer R, Marx R, Said SPL, editors. Pediatric Head and Neck Pathology. Cambridge: Cambrige University Press; 2017. p. 505\u201341."},{"key":"1257_CR3","doi-asserted-by":"crossref","DOI":"10.55418\/9781933477060","volume-title":"Benign Reaction Conditional lymph node spleen, Atlas nontumor Pathological first Series fascicle","author":"D O\u2019Malley","year":"2009","unstructured":"O\u2019Malley D. General reactive conditions in lymph node and spleen. In: O\u2019Malley D, George T, Orazi A, Abbondanzo S, editors. Benign Reaction Conditional lymph node spleen, Atlas nontumor Pathological first Series fascicle. Washinton, DC: ARP; 2009."},{"key":"1257_CR4","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/ajcp\/aqaa011","volume":"153","author":"KM Chisholm","year":"2020","unstructured":"Chisholm KM, Fleming MD. Histologic and laboratory characteristics of symptomatic and asymptomatic castleman disease in the pediatric population. Am J Clin Pathol. 2020;153:821\u201332.","journal-title":"Am J Clin Pathol"},{"key":"1257_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.blre.2017.11.005","volume":"32","author":"M Haap","year":"2018","unstructured":"Haap M, Wiefels J, Horger M, Hoyer A, M\u00fcssig K. Clinical, laboratory and imaging findings in Castleman\u2019s disease: the subtype decides. Blood Rev. 2018;32:225\u201334. https:\/\/doi.org\/10.1016\/j.blre.2017.11.005.","journal-title":"Blood Rev."},{"key":"1257_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.27613","volume":"66","author":"J Sopfe","year":"2019","unstructured":"Sopfe J, Endres A, Campbell K, Hayes K, Trout AT, Liang X, et al. Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two-site retrospective cohort study. Pediatr Blood Cancer. 2019;66:1\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"1257_CR7","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1016\/S2352-3026(16)00006-5","volume":"3","author":"AY Liu","year":"2016","unstructured":"Liu AY, Nabel CS, Finkelman BS, Ruth JR, Kurzrock R, van Rhee F, et al. Idiopathic multicentric Castleman\u2019s disease: a systematic literature review. Lancet Haematol. 2016;3:e163\u201375. https:\/\/doi.org\/10.1016\/S2352-3026(16)00006-5.","journal-title":"Lancet Haematol"},{"key":"1257_CR8","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010;362:1993\u20132000.","journal-title":"N Engl J Med"},{"key":"1257_CR9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/modpathol.2012.70","volume":"25","author":"A Louissaint","year":"2012","unstructured":"Louissaint A, Ferry JA, Soupir CP, Hasserjian RP, Harris NL, Zukerberg LR. Infectious mononucleosis mimicking lymphoma: distinguishing morphological and immunophenotypic features. Mod Pathol. 2012;25:1149\u201359.","journal-title":"Mod Pathol"},{"key":"1257_CR10","unstructured":"Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al. WHO classification of Tumours of Haematopoietic and Lymphoid Tissues. revised 4th edition. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, et al., editors. Lyon Cedex 08: International Agency for Research on Cancer (IARC); 2017."},{"key":"1257_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0031-3955(03)00024-5","volume":"50","author":"JT Albright","year":"2003","unstructured":"Albright JT, Pransky SM. Nontuberculous mycobacterial infections of the head and neck. Pediatr Clin N Am. 2003;50:503\u201314.","journal-title":"Pediatr Clin N Am."},{"key":"1257_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.1440-1827.2001.01254.x","volume":"51","author":"MH Lin","year":"2001","unstructured":"Lin MH, Kuo TT. Specificity of the histopathological triad for the diagnosis of toxoplasmic lymphadenitis: polymerase chain reaction study. Pathol Int. 2001;51:619\u201323.","journal-title":"Pathol Int"},{"key":"1257_CR13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/jcp.2005.026492","volume":"58","author":"M Eapen","year":"2005","unstructured":"Eapen M, Mathew CF, Aravindan KP. Evidence based criteria for the histopathological diagnosis of toxoplasmic lymphadenopathy. J Clin Pathol. 2005;58:1143\u20136.","journal-title":"J Clin Pathol"},{"key":"1257_CR14","first-page":"204","volume":"10","author":"M Onciu","year":"2003","unstructured":"Onciu M, Medeiros LJ. Kikuchi-Fujimoto. Lymphadenitis. 2003;10:204\u201311.","journal-title":"Lymphadenitis"},{"key":"1257_CR15","first-page":"219","volume":"37","author":"T-J Wang","year":"2004","unstructured":"Wang T-J, Yang Y-H, Lin Y-T, Chiang B-L. Kikuchi-Fujimoto disease in children: clinical features and disease course. J Microbiol Immunol Infect. 2004;37:219\u201324.","journal-title":"J Microbiol Immunol Infect."},{"key":"1257_CR16","first-page":"231","volume":"10","author":"RE Felgar","year":"1997","unstructured":"Felgar RE, Furth EE, Wasik MA, Gluckman SJ, Salhany KE. Histiocytic necrotizing lymphadenitis (Kikuchi\u2019s disease): in situ end-labeling, immunohistochemical, and serologic evidence supporting cytotoxic lymphocyte-mediated apoptotic cell death. Mod Pathol. 1997;10:231\u201341.","journal-title":"Mod Pathol."},{"key":"1257_CR17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/00000478-199006000-00002","volume":"14","author":"GA Chamulak","year":"1990","unstructured":"Chamulak GA, Brynes RK, Nathwani BN. Kikuchi-Fujimoto disease mimicking malignant lymphoma. Am J Surg Pathol. 1990;14:514\u201323.","journal-title":"Am J Surg Pathol."},{"key":"1257_CR18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","volume":"2016","author":"JT Sandlund","year":"2016","unstructured":"Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematology. 2016;2016:589\u201397.","journal-title":"Hematology"},{"key":"1257_CR19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11899-015-0277-y","volume":"10","author":"JT Sandlund","year":"2015","unstructured":"Sandlund JT. Non-Hodgkin Lymphoma in Children. Curr Hematol Malig Rep. 2015;10:237\u201343.","journal-title":"Curr Hematol Malig Rep"},{"key":"1257_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.ijom.2010.03.029","volume":"39","author":"S Etemad-Moghadam","year":"2010","unstructured":"Etemad-Moghadam S, Tirgary F, Keshavarz S, Alaeddini M. Head and neck non-Hodgkin\u2019s lymphoma: A 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg. 2010;39:869\u201372. https:\/\/doi.org\/10.1016\/j.ijom.2010.03.029.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1257_CR21","first-page":"2002","volume":"2007","author":"AA Tadbir","year":"2007","unstructured":"Tadbir AA, Mehrabani D, Heydari ST. M 1538. 2007;2007:2002\u20135.","journal-title":"M 1538"},{"key":"1257_CR22","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","volume":"23","author":"THM Keegan","year":"2005","unstructured":"Keegan THM, Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, et al. Epstein-Barr virus as a marker of survival after Hodgkin\u2019s lymphoma: a population-based study. J Clin Oncol. 2005;23:7604\u201313.","journal-title":"J Clin Oncol"},{"key":"1257_CR23","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1200\/JCO.2005.01.701","volume":"23","author":"A Claviez","year":"2005","unstructured":"Claviez A, Tiemann M, L\u00fcders H, Krams M, Parwaresch R, Schellong G, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin\u2019s lymphoma. J Clin Oncol. 2005;23:4048\u201356.","journal-title":"J Clin Oncol"},{"key":"1257_CR24","unstructured":"Urquhart A, Berg R. Hodgkin \u2019 s and Non-Hodgkin \u2019 s Lymphoma of the Head and Neck."},{"key":"1257_CR25","first-page":"261","volume":"29","author":"N Shamloo","year":"2017","unstructured":"Shamloo N, Ghannadan A, Jafari M, Ahmadi S, Mortazavi H, Baharvand M. Head and neck lymphoma in an Iranian population. Iran J Otorhinolaryngol. 2017;29:261\u20137.","journal-title":"Iran J Otorhinolaryngol"},{"key":"1257_CR26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1309\/33YCNMW08KNA36NT","volume":"123","author":"MP del Qui\u00f1ones-Avila","year":"2005","unstructured":"del Qui\u00f1ones-Avila MP, Gonzalez-Longoria AA, Admirand JH, Medeiros LJ. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases. Am J Clin Pathol. 2005;123:651\u20136.","journal-title":"Am J Clin Pathol."},{"key":"1257_CR27","first-page":"285","volume":"120","author":"CH Dunphy","year":"1996","unstructured":"Dunphy CH, Saravia O, Varvares MA. Hodgkin\u2019s disease primarily involving Waldeyer\u2019s ring. Case report and review of the literature. Arch Pathol Lab Med. 1996;120:285\u20137.","journal-title":"Arch Pathol Lab Med."},{"key":"1257_CR28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00000478-199512000-00010","volume":"19","author":"SB Kapadia","year":"1995","unstructured":"Kapadia SB, Roman LN, Kingma DW, Jaffe ES, Frizzera G. Hodgkin\u2019s disease of Waldeyer\u2019s ring. Clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases. Am J Surg Pathol. 1995;19:1431\u20139.","journal-title":"Am J Surg Pathol."},{"key":"1257_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0167-8140(85)80042-6","volume":"3","author":"L Cionini","year":"1985","unstructured":"Cionini L, Bastiani P, Biti GP, Mungai V, Ponticelli P, Di Lollo S. Waldeyer\u2019s ring (WR) involvement in Hodgkin\u2019s disease. Radiother Oncol. 1985;3:299\u2013302.","journal-title":"Radiother Oncol"},{"key":"1257_CR30","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1097-0142(19830515)51:10<1777::AID-CNCR2820511003>3.0.CO;2-E","volume":"51","author":"DP Burkitt","year":"1983","unstructured":"Burkitt DP. The discovery of Burkitt\u2019s lymphoma. Cancer. 1983;51:1777\u201386.","journal-title":"Cancer"},{"key":"1257_CR31","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3324\/haematol.2016.156885","volume":"102","author":"M Rohde","year":"2017","unstructured":"Rohde M, Bonn BR, Zimmermann M, Lange J, M\u00f6ricke A, Klapper W, et al. Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin lymphoma Berlin-Frankfurt-m\u00fcnster protocols. Haematologica. 2017;102:1091\u20138.","journal-title":"Haematologica"},{"key":"1257_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjh.13925","volume":"173","author":"V Havelange","year":"2016","unstructured":"Havelange V, Pepermans X, Ameye G, Th\u00e9ate I, Callet-Bauchu E, Barin C, et al. Genetic differences between paediatric and adult Burkitt lymphomas. Br J Haematol. 2016;173:137\u201344.","journal-title":"Br J Haematol"},{"key":"1257_CR33","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","volume":"104","author":"B Gonzalez-Farre","year":"2019","unstructured":"Gonzalez-Farre B, Ramis-Zaldivar JE, Salmeron-Villalobos J, Balagu\u00e9 O, Celis V, Verdu-Amoros J, et al. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma. Haematologica. 2019;104:1822\u20139.","journal-title":"Haematologica"},{"key":"1257_CR34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2009.07762.x","volume":"146","author":"U Thunberg","year":"2009","unstructured":"Thunberg U, Amini RM, Linderoth J, Roos G, Enblad G, Berglund M. BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution. Br J Haematol. 2009;146:683\u20134.","journal-title":"Br J Haematol"},{"key":"1257_CR35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14812","volume":"179","author":"M Szczepanowski","year":"2017","unstructured":"Szczepanowski M, Lange J, Kohler CW, Masque-Soler N, Zimmermann M, Aukema SM, et al. Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents. Br J Haematol. 2017;179:116\u20139.","journal-title":"Br J Haematol"},{"key":"1257_CR36","first-page":"742","volume":"8","author":"M Msimang","year":"2017","unstructured":"Msimang M, Ramdial P, Kuppusamy J, Nargan K, Sheik GM. AIDS-associated pdiatric high grade B-cell lymphoma with MYC and BCL2 translocations. J AIDS Clin Res. 2017;8:742.","journal-title":"J AIDS Clin Res."},{"key":"1257_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pathol.2019.08.013","volume":"52","author":"N Sukswai","year":"2020","unstructured":"Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52:53\u201367.","journal-title":"Pathology"},{"key":"1257_CR38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","volume":"135","author":"JE Ramis-Zaldivar","year":"2020","unstructured":"Ramis-Zaldivar JE, Gonzalez-Farr\u00e9 B, Balagu\u00e9 O, Celis V, Nadeu F, Salmer\u00f3n-Villalobos J, et al. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. Blood. 2020;135:274\u201386.","journal-title":"Blood"},{"key":"1257_CR39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/bjh.15145","volume":"181","author":"KA Nguyen","year":"2018","unstructured":"Nguyen KA, Su C, Bai HX, Zhang Z, Xiao R, Karakousis G, et al. Disease site as a determinant of survival outcome in patients with systemic anaplastic lymphoma kinase positive anaplastic large cell lymphoma with extranodal involvement: an analysis of 1306 cases from the US National Cancer Database. Br J Haematol. 2018;181:196\u2013204.","journal-title":"Br J Haematol"},{"key":"1257_CR40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","volume":"36","author":"SM Jaglowski","year":"2009","unstructured":"Jaglowski SM, Linden E, Termuhlen AM, Flynn JM. Lymphoma in adolescents and young adults. Semin Oncol. 2009;36:381\u2013418. https:\/\/doi.org\/10.1053\/j.seminoncol.2009.07.009.","journal-title":"Semin Oncol."},{"key":"1257_CR41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","volume":"475","author":"C Agostinelli","year":"2019","unstructured":"Agostinelli C, Akarca AU, Ramsay A, Rizvi H, Rodriguez-Justo M, Pomplun S, et al. Novel markers in pediatric-type follicular lymphoma. Virchows Arch. 2019;475:771\u20139.","journal-title":"Virchows Arch"},{"key":"1257_CR42","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2010.63","volume":"23","author":"KA Rizzo","year":"2010","unstructured":"Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, et al. Marginal zone lymphomas in children and the young adult population: characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol. 2010;23:866\u201373.","journal-title":"Mod Pathol"},{"key":"1257_CR43","first-page":"208","volume":"1","author":"The Writing Group of the Histiocyte Society","year":"1987","unstructured":"The Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208\u20139.","journal-title":"Lancet"},{"key":"1257_CR44","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jss.2014.03.063","volume":"190","author":"S Golpanian","year":"2014","unstructured":"Golpanian S, Tashiro J, Gerth DJ, Thaller SR. Pediatric histiocytoses in the United States: incidence and outcomes. J Surg Res. 2014;190:221\u20139. https:\/\/doi.org\/10.1016\/j.jss.2014.03.063.","journal-title":"J Surg Res."},{"key":"1257_CR45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1288\/00005537-198801000-00003","volume":"98","author":"LD Robinson","year":"1988","unstructured":"Robinson LD, Smith RJ, Rightmire J, Torpy JM, Fernbach DJ. Head and neck malignancies in children: an age-incidence study. Laryngoscope. 1988;98:11\u20133.","journal-title":"Laryngoscope"},{"key":"1257_CR46","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"J-F Emile","year":"2016","unstructured":"Emile J-F, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Review article revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672\u201382.","journal-title":"Blood"},{"key":"1257_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ctrv.2010.02.003","volume":"36","author":"P Kaatsch","year":"2010","unstructured":"Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36:277\u201385. https:\/\/doi.org\/10.1016\/j.ctrv.2010.02.003.","journal-title":"Cancer Treat Rev"},{"key":"1257_CR48","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/107327481402100409","volume":"21","author":"N Grana","year":"2014","unstructured":"Grana N. Langerhans cell histiocytosis. Cancer Control. 2014;21:328\u201334.","journal-title":"Cancer Control"},{"key":"1257_CR49","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s12519-019-00304-9","volume":"15","author":"AKC Leung","year":"2019","unstructured":"Leung AKC, Lam JM, Leong KF. Childhood Langerhans cell histiocytosis: a disease with many faces. World J Pediatr. 2019;15:536\u201345. https:\/\/doi.org\/10.1007\/s12519-019-00304-9.","journal-title":"World J Pediatr"},{"key":"1257_CR50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1288\/00005537-198705000-00002","volume":"97","author":"CK Anonsen","year":"1987","unstructured":"Anonsen CK, Donaldson SS. Langerhans\u2019 cell histiocytosis of the head and neck. Laryngoscope. 1987;97:537\u201342.","journal-title":"Laryngoscope"},{"key":"1257_CR51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.otohns.2006.03.019","volume":"135","author":"L Buchmann","year":"2006","unstructured":"Buchmann L, Emami A, Wei JL. Primary head and neck Langerhans cell histiocytosis in children. Otolaryngol Head Neck Surg. 2006;135:312\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1257_CR52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation-2015.1.571","volume":"2015","author":"J Haroche","year":"2015","unstructured":"Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematology. 2015;2015:571\u20138.","journal-title":"Hematology"},{"key":"1257_CR53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1067\/moe.2002.122340","volume":"94","author":"C Flaitz","year":"2002","unstructured":"Flaitz C, Allen C, Neville B, Hicks J. Juvenile xanthogranuloma of the oral cavity in children: a clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:345\u201352.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"1257_CR54","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/MPH.0000000000000027","volume":"36","author":"JT Murphy","year":"2014","unstructured":"Murphy JT, Soeken T, Megison S, Perez E. Juvenile xanthogranuloma: diverse presentations of noncutaneous disease. J Pediatr Hematol Oncol. 2014;36:641\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1257_CR55","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3324\/haematol.2019.219626","volume":"105","author":"G Goyal","year":"2020","unstructured":"Goyal G, Ravindran A, Young JR, Shah MV, Bennani NN, Patnaik MM, et al. Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease. Haematologica. 2020;105:348\u201357.","journal-title":"Haematologica"},{"key":"1257_CR56","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, et al. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131:2877\u201390.","journal-title":"Blood"},{"key":"1257_CR57","doi-asserted-by":"publisher","first-page":"109851","DOI":"10.1016\/j.ijporl.2019.109851","volume":"131","author":"MM Alwani","year":"2020","unstructured":"Alwani MM, Elghouche AN, Schueth EA, Campiti VJ, Matt BH, Yekinni AO. Manifestations of pediatric extranodal Rosai Dorfman disease in the head and neck. Int J Pediatr Otorhinolaryngol. 2020;131:109851. https:\/\/doi.org\/10.1016\/j.ijporl.2019.109851.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"1257_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.53.1","volume":"53","author":"E Takahashi","year":"2013","unstructured":"Takahashi E, Nakamura S. Histiocytic sarcoma: an updated literature review based on the 2008 WHO classification. J Clin Exp Hematop. 2013;53:1\u20138.","journal-title":"J Clin Exp Hematop"},{"key":"1257_CR59","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Lucas DR, Dewar R. Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis. Arch Pathol Lab Med. 2018;142:1322\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"1257_CR60","doi-asserted-by":"crossref","first-page":"20150393","DOI":"10.1259\/dmfr.20150393","volume":"45","author":"V Bhalla","year":"2016","unstructured":"Bhalla V, Khan N, Jones M, Kumar A, Latifaj B, Colmenero I, et al. A rare case of paediatric histiocytic sarcoma of the maxilla and mandible. Dentomaxillofacial Radiol. 2016;45:20150393.","journal-title":"Dentomaxillofacial Radiol"},{"key":"1257_CR61","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/IOP.0b013e3182a74e3b","volume":"30","author":"VK Aakalu","year":"2014","unstructured":"Aakalu VK, Patel RM, Lim J, Setabutr P. Orbital histiocytic sarcoma in a 2-year-old child. Ophthal Plast Reconstr Surg. 2014;30:e143\u20135.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"1257_CR62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2350\/09-03-0622-OA.1","volume":"13","author":"ECC Castro","year":"2010","unstructured":"Castro ECC, Blazquez C, Boyd J, Correa H, De Chadarevian JP, Felgar RE, et al. Clinicopathologic features of histiocytic lesions following ALL, with a review of the literature. Pediatr Dev Pathol. 2010;13:225\u201337.","journal-title":"Pediatr Dev Pathol"},{"key":"1257_CR63","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-016-1965-2","volume":"469","author":"Q Liu","year":"2016","unstructured":"Liu Q, Tomaszewicz K, Hutchinson L, Hornick JL, Woda B, Yu H. Somatic mutations in histiocytic sarcoma identified by next generation sequencing. Virchows Arch. 2016;469:233\u201341. https:\/\/doi.org\/10.1007\/s00428-016-1965-2.","journal-title":"Virchows Arch"},{"key":"1257_CR64","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1751-553X.2011.01361.x","volume":"33","author":"JM Klco","year":"2011","unstructured":"Klco JM, Welch JS, Nguyen TT, Hurley MY, Kreisel FH, Hassan A, et al. State of the art in myeloid sarcoma. Int J Lab Hematol. 2011;33:555\u201365.","journal-title":"Int J Lab Hematol"},{"key":"1257_CR65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5114\/wo.2016.65602","volume":"20","author":"M Samborska","year":"2016","unstructured":"Samborska M, Derwich K, Skalska-Sadowska J, Kurzawa P, Wachowiak J. Myeloid sarcoma in children: diagnostic and therapeutic difficulties. Wspolczesna Onkol. 2016;20:444\u20138.","journal-title":"Wspolczesna Onkol"},{"key":"1257_CR66","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.joms.2017.08.034","volume":"76","author":"A Gaal","year":"2018","unstructured":"Gaal A, Chisholm KM, Egbert M. How rare is an oral presentation of myeloid sarcoma in the infant? J Oral Maxillofac Surg. 2018;76:561\u20138. https:\/\/doi.org\/10.1016\/j.joms.2017.08.034.","journal-title":"J Oral Maxillofac Surg"},{"key":"1257_CR67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1177\/014556131609500902","volume":"95","author":"DW Cuthbertson","year":"2016","unstructured":"Cuthbertson DW, Punia JN, Owczarzak VL. Myeloid sarcomas of the head and neck in pediatric patients with myeloid leukemia. Ear Nose Throat J. 2016;95:405\u20137.","journal-title":"Ear Nose Throat J"},{"key":"1257_CR68","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.ijporl.2013.06.008","volume":"77","author":"BB Roby","year":"2013","unstructured":"Roby BB, Drehner D, Sidman JD. Granulocytic sarcoma of pediatric head and neck: an institutional experience. Int J Pediatr Otorhinolaryngol. 2013;77:1364\u20136. https:\/\/doi.org\/10.1016\/j.ijporl.2013.06.008.","journal-title":"Int J Pediatr Otorhinolaryngol."},{"key":"1257_CR69","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41379-018-0168-6","volume":"32","author":"KTE Chang","year":"2019","unstructured":"Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, et al. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol. 2019;32:598\u2013608.","journal-title":"Mod Pathol."},{"key":"1257_CR70","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00401-019-02027-7","volume":"138","author":"CHG Lucas","year":"2019","unstructured":"Lucas CHG, Gilani A, Solomon DA, Liang X, Maher OM, Chamyan G, et al. ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system. Acta Neuropathol. 2019;138:335\u20137. https:\/\/doi.org\/10.1007\/s00401-019-02027-7.","journal-title":"Acta Neuropathol"},{"key":"1257_CR71","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2008-03-147017","volume":"112","author":"JKC Chan","year":"2008","unstructured":"Chan JKC, Lamant L, Algar E, Delsol G, Tsang WYW, Lee KC, et al. ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy. Blood. 2008;112:2965\u20138.","journal-title":"Blood"},{"key":"1257_CR72","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pcl.2014.09.010","volume":"62","author":"CE Allen","year":"2015","unstructured":"Allen CE, Kelly KM, Bollard CM. Pediatric lymphomas and histiocytic disorders of childhood. Pediatr Clin N Am. 2015;62:139\u201365.","journal-title":"Pediatr Clin N Am"},{"key":"1257_CR73","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/bjh.12293","volume":"161","author":"GN Usmani","year":"2013","unstructured":"Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013;161:609\u201322.","journal-title":"Br J Haematol"},{"key":"1257_CR74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer."},{"key":"1257_CR75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/ajcp\/aqaa124","volume":"154","author":"A Prilutskiy","year":"2020","unstructured":"Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, et al. SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis. Am J Clin Pathol. 2020;154:466\u201374.","journal-title":"Am J Clin Pathol."},{"key":"1257_CR76","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/archderm.138.9.1208","volume":"138","author":"DS Morrell","year":"2002","unstructured":"Morrell DS, Pepping MA, Scott JP, Esterly NB, Drolet BA. Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol. 2002;138:1208\u201312.","journal-title":"Arch Dermatol"},{"key":"1257_CR77","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ijporl.2005.02.014","volume":"69","author":"TL Lindemann","year":"2005","unstructured":"Lindemann TL, Greene JS. Persistent cervical lymphadenopathy in an adolescent with Epstein-Barr induced hemophagocytic syndrome: manifestations of a rare but often fatal disease. Int J Pediatr Otorhinolaryngol. 2005;69:1011\u20134.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1257_CR78","first-page":"08","volume":"13","author":"S Lang","year":"2014","unstructured":"Lang S, Kansy B. Cervical lymph node diseases in children. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2014;13:08.","journal-title":"GMS Curr Top Otorhinolaryngol Head Neck Surg."},{"key":"1257_CR79","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5812\/pedinfect.4862","volume":"1","author":"RM Ghanaiee","year":"2013","unstructured":"Ghanaiee RM, Shiari R, Karimi A, Armin S, Fahimzad A, Shiva F, et al. A case series report of Iranian children: hemophagocytic lymphohistiocytosis syndrome. Arch Pediatr Infect Dis. 2013;1:31\u20135.","journal-title":"Arch Pediatr Infect Dis"},{"key":"1257_CR80","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijporl.2008.09.028","volume":"73","author":"MS Kong","year":"2009","unstructured":"Kong MS, Engel SH, Zalzal GH, Preciado D. Necrotizing epiglottitis and hemophagocytic lymphohistiocytosis. Int J Pediatr Otorhinolaryngol. 2009;73:119\u201325.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1257_CR81","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00000478-200604000-00014","volume":"30","author":"M Miettinen","year":"2006","unstructured":"Miettinen M, Fetsch JF. Reticulohistiocytoma (Solitary Epithelioid Histiocytoma). Am J Surg Pathol. 2006;30:521\u20138.","journal-title":"Am J Surg Pathol"},{"key":"1257_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13727","author":"E Bahrani","year":"2020","unstructured":"Bahrani E, Fernandez-Pol S, Wang JY, Aasi SZ, Brown RA, Novoa RA. Reticulohistiocytoma (solitary epithelioid histiocytoma) with mutations in RAF1 and TSC2. J Cutan Pathol. 2020. https:\/\/doi.org\/10.1111\/cup.13727.","journal-title":"J Cutan Pathol."},{"key":"1257_CR83","doi-asserted-by":"publisher","first-page":"104320","DOI":"10.1016\/j.yexmp.2019.104320","volume":"111","author":"BS Hoyt","year":"2019","unstructured":"Hoyt BS, Yan S, Linos KD, Momtahen S, Sriharan A, Tran TAN, et al. BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: testing may be useful in screening for Erdheim-Chester disease. Exp Mol Pathol. 2019;111:104320. https:\/\/doi.org\/10.1016\/j.yexmp.2019.104320.","journal-title":"Exp Mol Pathol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-020-01257-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-020-01257-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:40:46Z","timestamp":1744184446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-020-01257-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s12105-020-01257-6","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All author(s) declare that they have no conflict of interest as it relates to this research project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No external funding was obtained for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board, which did not require informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The views expressed in this [article, speech, presentation, etc.] are those of the author and do not reflect the official policy of the Department of Army\/Navy\/Air Force, Department of Defense, or U.S. Government.\u00a0Compliance With Ethical Standards Conflict of interest: All author(s) declare that they have no conflict of interest as it relates to this research project. Funding: No external funding was obtained for this study. Ethical approval: All procedures performed in this retrospective data analysis involving human participants were in accordance with the ethical standards of the institutional review board, which did not require informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}